SHR-A1811 Combined With Bevacizumab in HER2-positive Breast Cancer With Brain Metastases
Conditions: Breasr Cancer Interventions: Drug: SHR-A1811; Drug: Bevacizumab Sponsors: Huihua Xiong Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avastin | Brain | Brain Cancers | Breast Cancer | Cancer | Cancer & Oncology | HER2 | Neurology | Research